Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic ...

A new study from Penn Nursing suggests that a promising weight-loss drug, tirzepatide, could cause fewer unpleasant side ...

Weight loss injections seem to be more popular, but "compounded" versions of these drugs can vary in how people access them.

Whitney Leavitt is clearing the air about whether she used Ozempic injections to slim down after welcoming her third baby.

Only 1 in 10 of the prescriptions filled in the U.S. are for brand-name drugs; the vast majority are for generics, which are ...

For its part, OrderlyMeds looks to continue shifting the paradigm in weight loss through its whole-person approach to health ...

Novo Nordisk was downgraded to underweight by Morgan Stanley. Morgan Stanley analysts say a trial to test whether Novo Nordisk's blockbuster weight-loss drug also will work against Alzheimer's is ...

A new study from Penn Nursing has found that the popular weight-loss drug tirzepatide may cause fewer side effects like ...

At the end of Q2, the biotech has a cash balance of $808 million and burned $95 million in the 1H of the year. Viking ...

Additionally, researchers observed similar reductions in water usage and waste generation. Patients taking GLP-1 drugs also ...

If you thought the overdose crisis was only due to opioids, think again. Stimulants like cocaine and methamphetamines kill ...

Eli Lilly said in August that around 50 percent of employers had chosen to cover its weight-loss drug, Zepbound, little changed from a year earlier. Novo Nordisk said last month that about 40 million ...